You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade
|
|---|---|
| Published in |
Journal for Immunotherapy of Cancer, December 2014
|
| DOI | 10.1186/s40425-014-0042-0 |
| Pubmed ID | |
| Authors |
Evan J Lipson, Victor E Velculescu, Theresa S Pritchard, Mark Sausen, Drew M Pardoll, Suzanne L Topalian, Luis A Diaz |
| Abstract |
Assessment of therapeutic activity of drugs blocking immune checkpoints such as CTLA-4 and PD-1/PD-L1 can be challenging, as tumors may seem to enlarge or appear anew before regressing, due to intratumoral inflammation. We assessed whether circulating tumor DNA (ctDNA) levels could serve as an early indicator of true changes in tumor burden in patients undergoing treatment with these agents. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 215 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Netherlands | 1 | <1% |
| Ireland | 1 | <1% |
| Switzerland | 1 | <1% |
| Unknown | 211 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 48 | 22% |
| Student > Ph. D. Student | 35 | 16% |
| Other | 23 | 11% |
| Student > Bachelor | 20 | 9% |
| Student > Master | 17 | 8% |
| Other | 34 | 16% |
| Unknown | 38 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 73 | 34% |
| Biochemistry, Genetics and Molecular Biology | 41 | 19% |
| Agricultural and Biological Sciences | 32 | 15% |
| Immunology and Microbiology | 3 | 1% |
| Engineering | 3 | 1% |
| Other | 17 | 8% |
| Unknown | 46 | 21% |
Attention Score in Context
This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 March 2024.
All research outputs
#1,412,382
of 25,608,265 outputs
Outputs from Journal for Immunotherapy of Cancer
#355
of 3,470 outputs
Outputs of similar age
#18,291
of 362,024 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#1
of 63 outputs
Altmetric has tracked 25,608,265 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,470 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.7. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 362,024 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 63 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.